Merck KGaA said its cell-tumor treatment Pimicotinib met its primary endpoint in a late-stage trial. The German pharma company said Tuesday that its experimental drug showed significant improvement in ...

The Prix Galien USA Best Startup category recognizes outstanding innovation by therapeutics-focused life science companies that have not yet ...

The global cancer tissue diagnostic market is on track for significant growth, with a projected increase from USD 15,302.2 ...

Operator Good day, and welcome to the OPKO Health third quarter of 2024 financial results conference call. All participants ...

Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsYvonne Briggs - Alliance Advisor, ...

In August 2023, BD received FDA clearance for its BD Respiratory Viral Panel (RVP) for the BD MAXTM System. This innovative single molecular diagnostic combination test swiftly identified and ...

The company’s MI Cancer Seek is approved as a companion diagnostic for multiple cancer therapies, including MSD’s Keytruda, ...

The whole-exome sequencing and whole-transcriptome sequencing-based test is approved for molecular profiling of solid tumors.

Future Market Insights (FMI) has released a comprehensive analysis on the global fungal staining reagent market, revealing a promising growth trajectory. The market is estimated to be valued at USD ...

"We are very excited to receive FDA approval for our MI Cancer Seek test. The extensive rigor with which the FDA evaluates ...

insider-trading-volume I will like Merck better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.